The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers ... for Safe Medicines said the 1-minute ad is "misleading in its ...

Hims & Hers is under scrutiny for promoting compounded weight-loss ... medication used for long-term weight management. It is a peptide similar to the hormone glucagon-like peptide-1, modified ...

Hims & Hers revealed that it will make its Big Game debut with a minute-long ad highlighting its compounded GLP-1 weight loss drug ... GLP-1 drug offerings in May 2024. The digital pharmacy startup ...

Hims stock dropped sharply Friday after the U.S. Food and Drug Administration said the shortage of widely-used weight-loss ...

The company expanded into weight loss in late 2023 with oral medication kits and added compounded GLP-1 medications to its ...

The ad goes on to tout Hims & Hers' weight loss drugs ... to every GLP-1 customer, so they know the exact ingredients from FDA-regulated suppliers that are in the medications they receive ...

During Sunday’s Super Bowl, Hims & Hers Health ... to life-saving weight loss treatments.” The ad is just the latest flashpoint in a battle over compounded GLP-1 drugs.

Over 100 million Americans watched Hims & Hers (HIMS)’ controversial Super Bowl ad taking on the weight-loss ... are medications that work — but they are priced for profits, not patients.” The ...

Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply, the FDA declared ...